FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 24

Author

Admin 425 posts 0 comments

Featured News

Woodsville Guaranty Savings Bank Collaborates with Jack Henry to Position for…

Admin Jul 16, 2025
Jack Henry™ announced today that Woodsville Guaranty Savings Bank selected Jack Henry to improve efficiencies and…
Featured News

TIFIN Launches Multilingual AI Hub in India to Drive Financial Innovation

Admin Jul 15, 2025
TIFIN, the AI-powered platform for wealth and financial services, has launched a multilingual AI innovation hub in…
Featured News

Intel Doubles Layoffs in California Amid $19 Billion Loss

Admin Jul 14, 2025
Intel Corporation is facing a deep financial crisis, prompting it to more than double its planned layoffs in…
Banking

Banking and Tax Management: The Backbone of Financial Stability

Admin Jul 11, 2025
Banking and tax management play a critical role in maintaining economic equilibrium for individuals,…
Banking

Paychex Launches AI-Assisted Recruiting Tool to Empower Small Businesses

Admin Jul 10, 2025
Paychex, a leading provider of HR and payroll solutions, has introduced a new AI-assisted recruiting feature aimed…
Articles

How C-Suite Executives Can Use AI to Increase ROI

Admin Jul 8, 2025
In today’s rapidly evolving business landscape, artificial intelligence (AI) is no longer a futuristic…
Articles

Why Financial Tax Should Be Reduced on Food Items – A Call for Fairness on…

Admin Jul 7, 2025
Food is not a luxury—it's a basic necessity. Yet in many regions, essential food items are still subject to taxes…
Articles

A good credit score opens doors—lower interest rates, better loans, and increased…

Admin Jul 4, 2025
A good credit score is a powerful financial tool that can significantly impact your borrowing potential and…
Articles

Top Picks in Accounts Receivable Software for Modernization

Admin Jul 3, 2025
In today’s fast-paced business landscape, outdated invoicing and payment collection systems can significantly…
Articles

Stock Market: A Gateway to Financial Profits and Potential Losses

Admin Jul 2, 2025
Introduction The stock market is a dynamic financial arena where fortunes can be made — and lost — with…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • FinTech and Employee F&F Settlement: How Digital Financial Platforms Are Transforming the Employee Exit Process
    • How AI and Digital Innovation Are Transforming the Future of the FinTech Industry
    • The Power of Ecosystems for Banking
    • The Rise of Fintech: Transforming the Financial Landscape
    • Why Financial Services and Banks Need an Operational Data Layer

    ARTICLE

    Invitation to the presentation of ALK’s first six months (Q2) 2026 results on Thursday, 20 August 2026
    2026-08-13T14:06:44Z
    ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first six months of 2026 in the morning on Thursday, 20 August 2026.


    Early-Bird Deadline Approaches for 2nd Annual Guardian Initiative Charity Golf Tournament as Veterans Seek Sponsors to Play
    2026-08-13T14:00:00Z
    Players have until August 28 to take advantage of early-bird pricing for the September 28 charity tournament at Maderas Golf Club, while local veterans are seeking sponsors for the opportunity...


    Arisan Therapeutics Selected for NIAID Contract Award to Develop a Therapeutic Small Molecule Viral Entry Inhibitor as a Medical Countermeasure for Filovirus Infection
    2026-08-13T14:00:00Z
    Contract Valued at Up to $24 million Supports IND-Enabling Studies for Arisan’s Lead Candidate with Demonstrated Activity Against Multiple Ebolaviruses


    New MotherToBaby Study Targets Pregnancy Data Gap for Newer Eczema Treatment
    2026-08-13T13:55:00Z
    The FDA has determined that human pregnancy data for Ebglyss® remain insufficient. By enrolling U.S. and Canadian participants, this study will help generate the evidence needed to inform future treatment...


    Acentra Health Awarded Five-Year Contract Extension to Continue Utilization Management Services in Colorado
    2026-08-13T13:33:00Z
    Contract allows state to promote quality and cost-effective healthcare for 1.3 million Coloradans


    Meet Pomoni: Physician-Founded Polyphenol Brand Unveils New Name, New Olive Oil Supplement for Athletes
    2026-08-13T13:15:00Z
    Pomoni debuts Phenolia Endurance,Sponsors Iowa City's core4 Gravel Earth Series race


    OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
    2026-08-13T13:15:00Z
    Transaction provides additional non-dilutive capital and enhanced financial flexibility while preserving meaningful long-term royalty upside


    MapLight Therapeutics Announces $150 Million Private Placement Financing 
    2026-08-13T13:10:00Z
    SAN FRANCISCO and BOSTON, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central...


    CurePSP Establishes Public Policy and Advocacy Team to Accelerate National Impact
    2026-08-13T13:00:00Z
    NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- CurePSP has formally established its Public Policy and Advocacy team with the recent additions of Nora Wong, MPH, Associate Director of Public...


    Opción Yo Earns a Place Among the Top 3% of the Inc. 5000
    2026-08-13T12:51:07Z
    MIAMI, FL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- — This recognition reflects a profound cultural shift as more people prioritize emotional well-being with the same intention they have long invested...


    Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
    2026-08-13T12:51:00Z
    WOBURN, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT) in...


    SS Innovations Reports Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales


    Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    - Halneuron® Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026, 217 patients enrolled –


    PDS Biotech Reports Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    PRINCETON, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer, today...


    Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
    2026-08-13T12:30:00Z
    First lupus nephritis patient dosed in RECLAIM-LN, a Phase 2 potentially registrational trial utilizing FT819, an iPSC-derived, off-the-shelf CAR T-cell therapy; patient was treated as an outpatient with same-day discharge


    Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today...


    Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
    2026-08-13T12:30:00Z
    Cash and Cash Equivalents of $28.4 Million as of June 30, 2026 Providing Runway Through Mid-2027; Company Advances Chemistry, Manufacturing and Controls (CMC) Work Toward NDA Resubmission


    Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
    2026-08-13T12:05:00Z
    NEEDHAM, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for...


    WallabyPhenox Announces First Patient Enrolled in PROMISE Study Evaluating Treatment of Medium Vessel Occlusion Stroke
    2026-08-13T12:00:00Z
    IRVINE, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- WallabyPhenox today announced that the first patient has been enrolled in PROMISE (PROspective study on Management of Ischemic Stroke secondary to mEvo),...


    Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
    2026-08-13T12:00:00Z
    Clinical and Scientific Progress Across the Pipeline Supports Multiple Upcoming Milestones


    Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients
    2026-08-13T12:00:00Z
    VANCOUVER, British Columbia, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize...


    Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update
    2026-08-13T12:00:00Z
    PRINCETON, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of...


    Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit
    2026-08-13T12:00:00Z
    ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the...


    Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement 
    2026-08-13T12:00:00Z
    JUPITER, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI) (the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions across the life sciences,...


    Cannara Establishes Automatic Share Purchase Plan
    2026-08-13T12:00:00Z
    MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products...


    Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint
    2026-08-13T11:36:00Z
    Clearmind Medicine has received Independent Data and Safety Monitoring Board (DSMB) approval to advance its clinical evaluation of CMND‑100 in patients with Alcohol Use Disorder (AUD) - a key milestone...


    Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives
    2026-08-13T11:30:00Z
    Agreement marks achievement of Cerenome’s full-year 2026 commercial payer coverage objective for CNSide


    MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury
    2026-08-13T11:30:00Z
    NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering off-the-shelf allogeneic invariant natural killer T (iNKT) cell therapies for cancer and...


    Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
    2026-08-13T11:30:00Z
    Registrational RESET-Myositis® clinical data on track to be reported in mid-2027 to support 2H27 BLA submission for rese-cel


    Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
    2026-08-13T11:30:00Z
    - Q2 net ZEVASKYN® revenue increased 31% quarter-over-quarter to $11.4 million –

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.